Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that entered the public markets through a merger with LifeSci Acquisition Corp, a SPAC sponsored by LifeSci Capital LLC that completed its IPO in 2020. Focused on the healthcare technology and clinical research sector, Science 37 enables remote and patient-centric trial operations through its proprietary platform. The company filed an 8-K with the SEC on May 13, 2022, as part of its ongoing reporting obligations following the de-SPAC transaction, which closed in October 2021. Investors and researchers seeking complete filing history, sponsor data, and deal analytics on SNCE can sign up for full access at SpacDesk.